Varian Medical Systems Company Profile (NYSE:VAR)

About Varian Medical Systems (NYSE:VAR)

Varian Medical Systems logoVarian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:VAR
  • CUSIP: 92220P10
  • Web:
  • Market Cap: $9 billion
  • Outstanding Shares: 91,921,000
Average Prices:
  • 50 Day Moving Avg: $92.55
  • 200 Day Moving Avg: $89.25
  • 52 Week Range: $76.94 - $106.70
  • Trailing P/E Ratio: 31.58
  • Foreward P/E Ratio: 22.29
  • P/E Growth: 2.51
Sales & Book Value:
  • Annual Revenue: $3.25 billion
  • Price / Sales: 2.77
  • Book Value: $14.04 per share
  • Price / Book: 6.97
  • EBIDTA: $625.1 million
  • Net Margins: 10.35%
  • Return on Equity: 24.63%
  • Return on Assets: 11.17%
  • Debt-to-Equity Ratio: 0.16%
  • Current Ratio: 1.59%
  • Quick Ratio: 1.15%
  • Average Volume: 911,162 shs.
  • Beta: 0.69
  • Short Ratio: 9.96

Frequently Asked Questions for Varian Medical Systems (NYSE:VAR)

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) announced its quarterly earnings results on Wednesday, April, 26th. The company reported $0.89 EPS for the quarter, beating the Zacks' consensus estimate of $0.88 by $0.01. The firm had revenue of $655 million for the quarter, compared to analyst estimates of $639.26 million. Varian Medical Systems had a return on equity of 24.63% and a net margin of 10.35%. The business's revenue for the quarter was up 6.5% on a year-over-year basis. During the same period last year, the firm posted $1.09 earnings per share. View Varian Medical Systems' Earnings History.

When will Varian Medical Systems make its next earnings announcement?

Varian Medical Systems is scheduled to release their next quarterly earnings announcement on Tuesday, July, 25th 2017. View Earnings Estimates for Varian Medical Systems.

What guidance has Varian Medical Systems issued on next quarter's earnings?

Varian Medical Systems updated its FY17 earnings guidance on Wednesday, April, 26th. The company provided EPS guidance of $3.56-3.64 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.95. The company issued revenue guidance of +2-4%, compared to the consensus revenue estimate of $2.76 billion.Varian Medical Systems also updated its Q3 guidance to $0.92-0.96 EPS.

Where is Varian Medical Systems' stock going? Where will Varian Medical Systems' stock price be in 2017?

12 equities research analysts have issued 12-month price objectives for Varian Medical Systems' shares. Their forecasts range from $81.50 to $106.00. On average, they anticipate Varian Medical Systems' stock price to reach $92.14 in the next year. View Analyst Ratings for Varian Medical Systems.

What are analysts saying about Varian Medical Systems stock?

Here are some recent quotes from research analysts about Varian Medical Systems stock:

  • 1. According to Zacks Investment Research, "Varian Medical posted an impressive second quarter of fiscal 2017, beating the Zacks Consensus Estimate on both the counts. The company’s upbeat guidance for the coming quarters is a positive. On the flip side, Varian Medical underperformed the broader industry with respect to price performance on a year-to-date basis. Of the major concerns, intensifying local competition is a primary headwind. Varian Medical is a leading operator in the proton therapy market, where it faces competition from bigwigs like Hitachi, Ion Beam Applications and other. Intensifying competition is expected to increase R&D expenditures which will keep margins under pressure. Moreover, the Imaging Components’ business spin-off will be an overhang on the stock, at least in the near term. Added to this, the stock looks a tad expensive at the moment when compared to its own price range (over the last one year)." (4/28/2017)
  • 2. Jefferies Group LLC analysts commented, "We hosted VAR CEO and CFO for a lunch. Key takeaways: 1) VREX spin process was all inclusive; 2) F17 RemainCo outlook calls for HSD EPS growth; 3) RadOnc outlook stable on multiple fronts near and long-term; 3) next-gen linac expected in 2H17; 5) aim is to double Software in 5-years; 6) proton stable postCTCL with glimmers of light in tunnel; and 7) at least $1.0bn in debt capacity for M&A. We are publishing revised stand-alone estimates and PT of $88." (2/8/2017)

Who are some of Varian Medical Systems' key competitors?

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the folowing people:

  • R. Andrew Eckert, Independent Chairman of the Board
  • Dow R. Wilson, President, Chief Executive Officer
  • Timothy E. Guertin, Vice Chairman of the Board
  • Elisha W. Finney, Chief Financial Officer, Executive Vice President - Finance
  • Kolleen T. Kennedy, Executive Vice President and President - Oncology Systems
  • John W. Kuo, Senior Vice President, General Counsel, Corporate Secretary
  • Rafael Torres, Senior Vice President - Business Development and Strategy
  • Jose Baselga M.D., Ph.D., Director
  • Jean-Luc Butel, Director
  • Susan L. Bostrom, Independent Director

Who owns Varian Medical Systems stock?

Varian Medical Systems' stock is owned by a number of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.69%), BlackRock Inc. (8.49%), Loomis Sayles & Co. L P (6.86%), First Eagle Investment Management LLC (4.99%), State Street Corp (4.65%) and Janus Capital Management LLC (4.23%). Company insiders that own Varian Medical Systems stock include Clarence R Verhoef, Dow R Wilson, Elisha W Finney, John W Kuo, Mark R Laret, R Andrew Eckert, Ruediger Naumann-Etienne, Susan L Bostrom and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.

Who sold Varian Medical Systems stock? Who is selling Varian Medical Systems stock?

Varian Medical Systems' stock was sold by a variety of institutional investors in the last quarter, including AXA, Bank of New York Mellon Corp, Acadian Asset Management LLC, Morgan Stanley, Gotham Asset Management LLC, Martingale Asset Management L P, Old Mutual Global Investors UK Ltd. and Ameriprise Financial Inc.. Company insiders that have sold Varian Medical Systems stock in the last year include Clarence R Verhoef, Dow R Wilson, Elisha W Finney, John W Kuo, Mark R Laret, Ruediger Naumann-Etienne, Susan L Bostrom and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.

Who bought Varian Medical Systems stock? Who is buying Varian Medical Systems stock?

Varian Medical Systems' stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Wells Fargo & Company MN, FMR LLC, Point72 Asset Management L.P., First Eagle Investment Management LLC, Janus Capital Management LLC, Vanguard Group Inc. and Quantitative Investment Management LLC. View Insider Buying and Selling for Varian Medical Systems.

How do I buy Varian Medical Systems stock?

Shares of Varian Medical Systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of Varian Medical Systems stock can currently be purchased for approximately $97.87.

MarketBeat Community Rating for Varian Medical Systems (NYSE VAR)
Community Ranking:  2.6 out of 5 ( )
Outperform Votes:  270 (Vote Outperform)
Underperform Votes:  243 (Vote Underperform)
Total Votes:  513
MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Varian Medical Systems (NYSE:VAR) (?)
Ratings Breakdown: 3 Sell Ratings, 5 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.08)
Consensus Price Target: $92.14 (5.86% downside)

Analysts' Ratings History for Varian Medical Systems (NYSE:VAR)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/17/2017AegisReiterated RatingHold$91.00LowView Rating Details
5/16/2017Goldman Sachs Group IncInitiated CoverageNeutral -> Neutral$92.00LowView Rating Details
5/15/2017Citigroup IncUpgradeNeutral -> BuyLowView Rating Details
5/11/2017Jefferies Group LLCReiterated RatingBuyLowView Rating Details
5/8/2017BTIG ResearchUpgradeNeutral -> Buy$106.00HighView Rating Details
4/27/2017Barrington ResearchDowngradeOutperform -> Market PerformHighView Rating Details
4/27/2017Royal Bank of CanadaBoost Price TargetSector Perform -> Sector Perform$82.00 -> $90.00HighView Rating Details
4/24/2017Off Wall StreetInitiated CoverageSellLowView Rating Details
1/26/2017Evercore ISIDowngradeHold -> Sell$81.50N/AView Rating Details
9/28/2016Robert W. BairdBoost Price TargetNeutral$91.00 -> $99.00N/AView Rating Details
7/28/2016Morgan StanleyBoost Price TargetUnderweight$80.00 -> $86.00N/AView Rating Details
7/28/2016Brean CapitalBoost Price TargetBuy$87.00 -> $90.00N/AView Rating Details
10/20/2015JPMorgan Chase & Co.Reiterated RatingNeutral$95.00 -> $75.00N/AView Rating Details
6/18/2015Dougherty & CoInitiated CoverageBuy$105.00N/AView Rating Details
(Data available from 5/29/2015 forward)


Earnings History for Varian Medical Systems (NYSE:VAR)
Earnings by Quarter for Varian Medical Systems (NYSE:VAR)
Earnings History by Quarter for Varian Medical Systems (NYSE:VAR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/26/2017Q2 2017$0.88$0.89$639.26 million$655.00 millionViewN/AView Earnings Details
10/26/2016Q4112$1.34$1.38$880.29 million$912.00 millionViewListenView Earnings Details
7/27/2016Q316$1.17$1.22$779.90 million$789.40 millionViewListenView Earnings Details
4/27/2016Q216$1.08$1.09$769.56 million$758.80 millionViewListenView Earnings Details
1/27/2016Q116$0.94$0.99$748.01 million$757.00 millionViewListenView Earnings Details
10/28/2015Q4$1.10$1.04$813.18 million$817.80 millionViewListenView Earnings Details
7/29/2015Q3$1.10$1.13$810.41 million$784.00 millionViewListenView Earnings Details
4/29/2015Q215$1.00$1.05$799.66 million$759.40 millionViewN/AView Earnings Details
1/28/2015Q115$0.87$0.99$720.83 million$737.90 millionViewN/AView Earnings Details
10/22/2014Q415$1.21$1.02$837.86 million$812.10 millionViewListenView Earnings Details
7/23/2014Q314$1.09$1.08$767.52 million$747.70 millionViewN/AView Earnings Details
4/23/2014Q4112$1.03$1.04$772.84 million$779.00 millionViewN/AView Earnings Details
1/22/2014Q3112$0.90$0.91$718.23 million$712.00 millionViewN/AView Earnings Details
10/23/2013Q3112$1.12$1.08$779.02 million$770.00 millionViewN/AView Earnings Details
7/24/2013Q3 2013$1.01$1.03$749.01 million$726.20 millionViewN/AView Earnings Details
4/24/2013Q2 2013$1.02$1.04$758.02 million$768.40 millionViewN/AView Earnings Details
1/23/2013Q1 2013$0.87$0.86$676.15 million$678.40 millionViewN/AView Earnings Details
10/25/2012$1.03$1.08ViewN/AView Earnings Details
7/25/2012$0.94$0.96ViewN/AView Earnings Details
4/25/2012$0.96$0.96ViewN/AView Earnings Details
1/25/2012$0.75$0.79ViewN/AView Earnings Details
10/27/2011$0.97$0.95ViewN/AView Earnings Details
7/27/2011$0.83$0.83ViewN/AView Earnings Details
4/27/2011$0.85$0.86ViewN/AView Earnings Details
1/26/2011$0.73$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Varian Medical Systems (NYSE:VAR)
2017 EPS Consensus Estimate: $4.15
2018 EPS Consensus Estimate: $4.48
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$1.04$1.06$1.05
Q2 20172$0.91$1.08$1.00
Q3 20172$0.94$0.95$0.95
Q4 20172$1.12$1.19$1.16
Q1 20182$0.92$1.03$0.98
Q2 20182$1.03$1.07$1.05
Q3 20182$1.07$1.17$1.12
Q4 20182$1.27$1.39$1.33
(Data provided by Zacks Investment Research)


Dividend History for Varian Medical Systems (NYSE:VAR)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Varian Medical Systems (NYSE:VAR)
Insider Ownership Percentage: 0.91%
Institutional Ownership Percentage: 99.79%
Insider Trades by Quarter for Varian Medical Systems (NYSE:VAR)
Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)
Insider Trades by Quarter for Varian Medical Systems (NYSE:VAR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/12/2017John W KuoSVPSell862$96.39$83,088.18View SEC Filing  
5/2/2017Susan L BostromDirectorSell3,589$91.08$326,886.12View SEC Filing  
4/12/2017John W KuoSVPSell864$89.74$77,535.36View SEC Filing  
3/17/2017John W KuoSVPSell3,876$91.75$355,623.00View SEC Filing  
3/13/2017John W KuoSVPSell862$87.89$75,761.18View SEC Filing  
3/1/2017John W KuoSVPSell10,353$84.81$878,037.93View SEC Filing  
1/5/2017Dow R WilsonInsiderSell13,334$88.74$1,183,259.16View SEC Filing  
12/8/2016John W KuoSVPSell1,267$90.33$114,448.11View SEC Filing  
12/5/2016Dow R WilsonInsiderSell10,000$90.03$900,300.00View SEC Filing  
11/7/2016Dow R WilsonInsiderSell10,000$90.59$905,900.00View SEC Filing  
10/31/2016Timothy E GuertinDirectorSell4,000$90.32$361,280.00View SEC Filing  
10/20/2016John W KuoSVPSell21,266$103.70$2,205,284.20View SEC Filing  
10/5/2016Dow R WilsonInsiderSell10,000$99.44$994,400.00View SEC Filing  
10/3/2016Elisha W FinneyCFOSell4,668$98.87$461,525.16View SEC Filing  
9/15/2016John W KuoSVPSell4,073$95.47$388,849.31View SEC Filing  
9/7/2016Elisha W FinneyCFOSell9,000$96.95$872,550.00View SEC Filing  
9/6/2016Dow R WilsonInsiderSell10,000$96.08$960,800.00View SEC Filing  
9/1/2016Elisha W FinneyCFOSell2,000$95.82$191,640.00View SEC Filing  
8/5/2016Dow R WilsonInsiderSell10,000$95.14$951,400.00View SEC Filing  
8/1/2016Clarence R VerhoefSVPSell9,483$94.88$899,747.04View SEC Filing  
8/1/2016Elisha W FinneyCFOSell25,334$94.90$2,404,196.60View SEC Filing  
8/1/2016Timothy E. GuertinDirectorSell4,000$94.88$379,520.00View SEC Filing  
7/5/2016Dow R WilsonCEOSell10,000$82.08$820,800.00View SEC Filing  
6/27/2016Dow R WilsonCEOSell10,000$78.27$782,700.00View SEC Filing  
6/8/2016Ruediger Naumann-EtienneDirectorSell1,000$84.83$84,830.00View SEC Filing  
6/3/2016Mark R LaretDirectorSell1,545$83.48$128,976.60View SEC Filing  
5/2/2016Timothy E. GuertinDirectorSell4,000$81.55$326,200.00View SEC Filing  
4/20/2016Elisha W FinneyCFOSell4,000$85.95$343,800.00View SEC Filing  
4/18/2016Clarence R VerhoefSVPSell2,500$85.00$212,500.00View SEC Filing  
3/23/2016Dow R WilsonCEOSell45,650$78.86$3,599,959.00View SEC Filing  
3/10/2016Ruediger Naumann-EtienneDirectorSell428$77.99$33,379.72View SEC Filing  
3/7/2016Timothy E. GuertinDirectorSell4,000$79.47$317,880.00View SEC Filing  
2/17/2016Elisha W. FinneyCFOSell2,454$78.59$192,859.86View SEC Filing  
12/7/2015Dow R. WilsonCEOSell9,000$80.00$720,000.00View SEC Filing  
12/2/2015R Andrew EckertDirectorSell3,000$81.67$245,010.00View SEC Filing  
11/24/2015Elisha W. FinneyCFOSell2,334$80.90$188,820.60View SEC Filing  
11/6/2015Dow R. WilsonCEOSell18,000$80.26$1,444,680.00View SEC Filing  
9/8/2015Dow R. WilsonCEOSell9,000$80.05$720,450.00View SEC Filing  
7/6/2015Dow R WilsonCEOSell9,000$85.80$772,200.00View SEC Filing  
7/2/2015Elisha W FinneyCFOSell2,000$85.95$171,900.00View SEC Filing  
7/1/2015Timothy E GuertinDirectorSell25,000$84.20$2,105,000.00View SEC Filing  
6/5/2015Dow R WilsonCEOSell9,000$86.29$776,610.00View SEC Filing  
6/1/2015Elisha W FinneyCFOSell2,000$85.99$171,980.00View SEC Filing  
6/1/2015Timothy E GuertinDirectorSell25,000$86.08$2,152,000.00View SEC Filing  
5/6/2015Dow R WilsonCEOSell9,000$86.64$779,760.00View SEC Filing  
4/17/2015Dow R WilsonCEOSell18,760$93.63$1,756,498.80View SEC Filing  
4/1/2015Elisha W FinneyCFOSell5,000$92.76$463,800.00View SEC Filing  
4/1/2015Timothy E GuertinDirectorSell25,000$92.76$2,319,000.00View SEC Filing  
3/20/2015Dow R WilsonCEOSell18,759$94.44$1,771,599.96View SEC Filing  
3/16/2015Kolleen T KennedyEVPSell1,972$95.00$187,340.00View SEC Filing  
3/6/2015Timothy E GuertinDirectorSell4,000$93.50$374,000.00View SEC Filing  
3/2/2015Elisha W FinneyCFOSell5,000$93.44$467,200.00View SEC Filing  
3/2/2015Timothy E GuertinDirectorSell50,000$93.48$4,674,000.00View SEC Filing  
2/23/2015Elisha W FinneyCFOSell1,326$92.97$123,278.22View SEC Filing  
2/10/2015Mark R LaretDirectorSell10,000$92.32$923,200.00View SEC Filing  
2/3/2015Venkatraman ThyagarajanDirectorSell10,000$92.71$927,100.00View SEC Filing  
2/2/2015Dow R WilsonCEOSell60,000$91.78$5,506,800.00View SEC Filing  
2/2/2015Elisha W FinneyCFOSell6,667$91.79$611,963.93View SEC Filing  
2/2/2015John W KuoSVPSell3,490$92.04$321,219.60View SEC Filing  
2/2/2015Ruediger Naumann-EtienneDirectorSell10,000$91.87$918,700.00View SEC Filing  
1/5/2015Timothy E GuertinDirectorSell50,000$86.27$4,313,500.00View SEC Filing  
1/2/2015Elisha W FinneyCFOSell15,000$87.05$1,305,750.00View SEC Filing  
12/11/2014Timothy E GuertinDirectorSell105,000$86.67$9,100,350.00View SEC Filing  
12/1/2014Elisha W FinneyCFOSell21,000$88.72$1,863,120.00View SEC Filing  
11/24/2014Elisha W FinneyCFOSell2,930$88.24$258,543.20View SEC Filing  
11/17/2014Elisha W FinneyCFOSell1,837$87.71$161,123.27View SEC Filing  
11/11/2014Kolleen T KennedySVPSell1,242$85.79$106,551.18View SEC Filing  
11/10/2014Ruediger Naumann-EtienneDirectorSell5,000$85.31$426,550.00View SEC Filing  
11/3/2014Elisha W FinneyCFOSell25,000$83.82$2,095,500.00View SEC Filing  
11/3/2014Timothy E GuertinDirectorSell80,000$83.72$6,697,600.00View SEC Filing  
10/29/2014Elisha W FinneyCFOSell10,000$83.95$839,500.00View SEC Filing  
10/27/2014Kolleen T KennedySVPSell1,240$81.00$100,440.00View SEC Filing  
10/1/2014Elisha W FinneyCFOSell15,000$79.98$1,199,700.00View SEC Filing  
9/11/2014John W KuoSVPSell605$85.82$51,921.10View SEC Filing  
9/2/2014Elisha W FinneyCFOSell20,000$85.18$1,703,600.00View SEC Filing  
8/20/2014Venkatraman ThyagarajanDirectorSell5,000$84.25$421,250.00View SEC Filing  
8/7/2014Elisha W FinneyCFOSell5,000$83.95$419,750.00View SEC Filing  
8/1/2014Elisha W FinneyCFOSell15,000$81.66$1,224,900.00View SEC Filing  
8/1/2014Timothy E GuertinDirectorSell80,000$81.69$6,535,200.00View SEC Filing  
7/9/2014John W KuoSVPSell582$85.00$49,470.00View SEC Filing  
7/1/2014Elisha W FinneyCFOSell20,000$83.86$1,677,200.00View SEC Filing  
6/23/2014John W KuoSVPSell1,745$85.00$148,325.00View SEC Filing  
6/16/2014Kolleen T KennedySVPSell1,416$82.42$116,706.72View SEC Filing  
6/2/2014Elisha W FinneyCFOSell10,000$82.35$823,500.00View SEC Filing  
5/12/2014Kolleen KennedySVPSell1,417$81.96$116,137.32View SEC Filing  
5/1/2014Elisha FinneyCFOSell10,000$78.99$789,900.00View SEC Filing  
5/1/2014Timothy GuertinDirectorSell80,000$78.98$6,318,400.00View SEC Filing  
4/11/2014Kolleen T KennedySVPSell640$72.15$46,176.00View SEC Filing  
4/1/2014Elisha FinneyCFOSell10,000$83.97$839,700.00View SEC Filing  
3/17/2014Clarence VerhoefSVPSell1,140$84.70$96,558.00View SEC Filing  
3/11/2014Kolleen KennedySVPSell1,417$84.39$119,580.63View SEC Filing  
3/10/2014Timothy GuertinDirectorSell80,000$84.05$6,724,000.00View SEC Filing  
3/3/2014Elisha FinneyCFOSell10,000$83.41$834,100.00View SEC Filing  
2/21/2014Mark LaretDirectorSell1,411$84.06$118,608.66View SEC Filing  
2/11/2014Kolleen KennedySVPSell1,416$80.59$114,115.44View SEC Filing  
2/10/2014R Andrew EckertDirectorSell5,887$80.52$474,021.24View SEC Filing  
2/3/2014Elisha FinneyCFOSell10,000$79.34$793,400.00View SEC Filing  
2/3/2014Timothy GuertinDirectorSell27,000$79.34$2,142,180.00View SEC Filing  
1/31/2014Susan BostromDirectorSell18,900$81.50$1,540,350.00View SEC Filing  
1/2/2014Elisha FinneyCFOSell24,321$77.69$1,889,498.49View SEC Filing  
1/2/2014Richard LevyDirectorSell20,000$77.68$1,553,600.00View SEC Filing  
12/30/2013John KuoSVPSell3,027$77.08$233,321.16View SEC Filing  
12/23/2013Clarence VerhoefSVPSell1,297$76.13$98,740.61View SEC Filing  
12/9/2013Dow WilsonCEOSell95,000$79.09$7,513,550.00View SEC Filing  
12/4/2013Robert KlugeSVPSell12,932$80.00$1,034,560.00View SEC Filing  
12/2/2013Elisha FinneyCFOSell10,000$79.04$790,400.00View SEC Filing  
12/2/2013Richard LevyDirectorSell20,000$79.04$1,580,800.00View SEC Filing  
12/2/2013Robert KlugeSVPSell9,889$79.00$781,231.00View SEC Filing  
11/29/2013Kolleen KennedySVPSell9,307$78.00$725,946.00View SEC Filing  
11/25/2013Kolleen KennedySVPSell2,972$75.49$224,356.28View SEC Filing  
11/22/2013Elisha FinneyCFOSell1,617$74.83$121,000.11View SEC Filing  
11/14/2013Elisha FinneyCFOSell5,000$74.95$374,750.00View SEC Filing  
11/1/2013Elisha W FinneyCFOSell5,000$72.27$361,350.00View SEC Filing  
11/1/2013Richard M LevyDirectorSell20,000$72.27$1,445,400.00View SEC Filing  
10/14/2013Robert KlugeSVPSell13,889$78.00$1,083,342.00View SEC Filing  
10/10/2013Robert KlugeSVPSell13,871$77.00$1,068,067.00View SEC Filing  
9/20/2013Kolleen KennedySVPSell1,247$76.00$94,772.00View SEC Filing  
9/16/2013Elisha FinneyCFOSell16,334$74.95$1,224,233.30View SEC Filing  
9/16/2013Kolleen KennedySVPSell2,562$75.00$192,150.00View SEC Filing  
9/11/2013Elisha W FinneyCFOSell23,666$74.95$1,773,766.70View SEC Filing  
9/3/2013Elisha FinneyCFOSell5,000$70.95$354,750.00View SEC Filing  
9/3/2013Richard LevyDirectorSell20,000$70.95$1,419,000.00View SEC Filing  
8/8/2013Kolleen KennedySVPSell2,400$73.50$176,400.00View SEC Filing  
8/1/2013Elisha W FinneyCFOSell5,000$72.81$364,050.00View SEC Filing  
8/1/2013R Andrew EckertDirectorSell1,375$72.93$100,278.75View SEC Filing  
7/19/2013John W KuoSVPSell1,817$72.00$130,824.00View SEC Filing  
7/17/2013Richard M LevyDirectorSell20,000$70.00$1,400,000.00View SEC Filing  
7/16/2013Elisha W FinneyCFOSell5,000$69.95$349,750.00View SEC Filing  
6/17/2013Elisha W FinneyCFOSell5,000$69.95$349,750.00View SEC Filing  
6/17/2013Richard M LevyDirectorSell20,000$70.00$1,400,000.00View SEC Filing  
6/10/2013Timothy E GuertinDirectorSell27,000$68.81$1,857,870.00View SEC Filing  
5/21/2013Elisha W FinneyCFOSell2,313$69.86$161,586.18View SEC Filing  
5/14/2013Elisha W FinneyCFOSell5,000$69.95$349,750.00View SEC Filing  
5/14/2013John W KuoSVPSell1,112$70.00$77,840.00View SEC Filing  
5/14/2013Richard M LevyDirectorSell20,000$70.00$1,400,000.00View SEC Filing  
2/14/2013John W KuoSVPSell1,111$71.05$78,936.55View SEC Filing  
9/4/2012Kolleen T KennedySVPSell1,900$64.00$121,600.00View SEC Filing  
8/20/2012Elisha W FinneyCFOSell4,000$59.95$239,800.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Varian Medical Systems (NYSE:VAR)
Latest Headlines for Varian Medical Systems (NYSE:VAR)
DateHeadline logoVarian Medical Systems, Inc. (VAR) Upgraded to Buy by Citigroup Inc - May 28 at 8:56 PM logoExperts Present New Radiosurgery Techniques Using Varian Technology for Optimal Targeting of Multiple Metastases - May 27 at 6:35 AM logoResearch Reports Coverage on Healthcare Stocks -- Biocept, Varian Medical Systems, Hill-Rom, and Tivity Health - PR Newswire (press release) - May 24 at 8:27 AM logoVarian Selected to Provide First Proton Therapy System in Thailand - May 24 at 8:27 AM logoVarian Medical Systems, Inc. (VAR) Given "Hold" Rating at Aegis - May 17 at 10:26 PM logoGoldman Sachs Group Inc Initiates Coverage on Varian Medical Systems, Inc. (VAR) - May 16 at 8:56 PM logoVarian Medical Systems, Inc. Expected to Post FY2017 Earnings of $3.94 Per Share (VAR) - May 15 at 8:20 AM logoInsider Selling: Varian Medical Systems, Inc. (VAR) SVP Sells 862 Shares of Stock - May 12 at 8:28 PM logoVarian Medical Systems, Inc. to Post Q3 2017 Earnings of $0.95 Per Share, Jefferies Group Forecasts (VAR) - May 12 at 10:58 AM logoVarian Medical Systems, Inc. (VAR) Given "Buy" Rating at Jefferies Group LLC - May 11 at 11:09 AM logoVarian ProBeam Proton Therapy System Receives Shonin Approval - May 10 at 10:00 AM logoNew Varian Cancer Treatment Platform Draws Large Crowds at ESTRO 36 Tradeshow - May 8 at 9:17 AM logoVarian Selected to Provide Compact Single-room Proton Therapy System for Treatment Center in Florida - May 8 at 9:17 AM logoVarian Launches Game-Changing Treatment Platform to Answer the Global Cancer Challenge - May 6 at 8:05 AM logoJust in case … Here’s what will happen to markets on Monday if Le Pen wins - May 6 at 12:54 AM logoVarex Imaging Announces Financial Results For The Second Quarter Of Fiscal Year 2017 - May 5 at 3:07 AM logoVarian Medical Systems (VAR) Given News Impact Score of 0.18 - May 4 at 4:48 PM logo Brokerages Anticipate Varian Medical Systems, Inc. (VAR) Will Announce Earnings of $0.94 Per Share - May 4 at 7:46 AM logoInsider Selling: Varian Medical Systems, Inc. (VAR) Director Sells 3,589 Shares of Stock - May 3 at 11:06 PM logoVarian Medical Systems, Inc. (VAR) Receives Average Rating of "Hold" from Brokerages - May 2 at 8:20 PM logoVarian Medical Systems (VAR) Given News Impact Score of 0.07 - May 1 at 7:10 PM logoKey Highlights of Varian Medical Systems’ Fiscal 2Q17 Earnings - May 1 at 10:26 AM logoVAR’s Latest Analyst Recommendations after Its 2Q17 Results - May 1 at 10:26 AM logoVarian Medical Systems, Inc. (VAR) Price Target Increased to $90.00 by Analysts at Royal Bank of Canada - April 30 at 11:29 AM logoVarian Medical Systems, Inc. (VAR) Lifted to B+ at TheStreet - April 29 at 11:04 AM logoVarian Medical (VAR) Beats on Earnings and Revenues in Q2 - Yahoo Finance - April 29 at 8:26 AM logoVarian Medical Systems (VAR) Earning Somewhat Favorable Press Coverage, Analysis Finds - April 28 at 2:31 PM logoVarian Medical Systems, Inc. (VAR) Stock Rating Lowered by Zacks Investment Research - April 28 at 1:02 PM logoBarrington Research Analysts Decrease Earnings Estimates for Varian Medical Systems, Inc. (VAR) - April 28 at 12:32 PM logoEdited Transcript of VAR earnings conference call or presentation 26-Apr-17 9:00pm GMT - April 27 at 10:48 PM logoVarian Medical Systems, Inc. (VAR) Stock Rating Lowered by Barrington Research - April 27 at 2:00 PM logoVarian Medical Systems (VAR) Q2 2017 Results - Earnings Call Transcript - April 27 at 11:28 AM logoVarian Spotlights World-Leading Systems for Advanced Radiotherapy, Radiosurgery, Brachytherapy and Proton Therapy at ESTRO 36 - April 27 at 11:28 AM logoVarian Medical (VAR) Beats on Earnings and Revenues in Q2 - April 27 at 11:28 AM logoVarian Medical Systems, Inc. (VAR) Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS - April 26 at 10:04 PM logoVarian Medical Systems, Inc. (VAR) Issues FY17 Earnings Guidance - April 26 at 7:10 PM logoVarian Medical Systems, Inc. (VAR) Releases Q3 Earnings Guidance - April 26 at 7:10 PM logoEarnings Reaction History: Varian Medical Systems, 75.0% Follow-Through Indicator, 5.0% Sensitive - April 26 at 5:02 PM logoBRIEF-Varian Medical Systems Q2 non-gaap EPS $0.89 from continuing operations - April 26 at 5:02 PM logoVarian Medical Systems Reports Results for Second Quarter of Fiscal Year 2017 - April 26 at 5:02 PM logoVarian beats Street 2Q forecasts - April 26 at 4:43 PM logoVarian Medical Systems (VAR) Given Daily Media Impact Score of 0.23 - April 25 at 3:32 PM logoInteresting VAR Put And Call Options For June 16th - April 24 at 6:51 PM logoVarian Medical Systems, Inc. (VAR) Research Coverage Started at Off Wall Street - April 24 at 2:10 PM logoVarian Medical Systems (VAR) Given News Impact Rating of 0.09 - April 22 at 1:13 PM logoVarian Medical Systems (VAR) Receives Daily News Sentiment Score of -0.12 - April 19 at 9:39 AM logoVarian Medical Systems, Inc. (VAR) Expected to Post Quarterly Sales of $643.13 Million - April 15 at 9:52 AM logoJohn W. Kuo Sells 864 Shares of Varian Medical Systems, Inc. (VAR) Stock - April 13 at 10:58 PM logoVarian Medical Systems (VAR) Given Media Impact Score of 0.26 - April 13 at 2:32 PM logo$0.88 Earnings Per Share Expected for Varian Medical Systems, Inc. (VAR) This Quarter - April 13 at 8:46 AM



Varian Medical Systems (VAR) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by Staff